| Patent | Date |
|---|
Combination Of Topoisomerase-i Inhibitors With Immunotherapy In The Treatment Of Cancer
App 20210205293 - HWU; Patrick ; et al. | 2021-07-08 |
Slc45a2 Peptides For Immunotherapy
App 20210170002 - Lizee; Gregory ; et al. | 2021-06-10 |
Methods For Identifying Rna Editing-derived Epitopes That Elicit Immune Responses In Cancer
App 20210172961 - ZHANG; Minying ; et al. | 2021-06-10 |
Combination of topoisomerase-I inhibitors with immunotherapy in the treatment of cancer
Grant 10,894,044 - Hwu , et al. January 19, 2 | 2021-01-19 |
Methods Of Cd40 And Toll Like Receptor Immune Activation
App 20200353044 - OVERWIJK; Willem ; et al. | 2020-11-12 |
Methods Of Cd40 Activation And Immune Checkpoint Blockade
App 20200165339 - OVERWIJK; Willem W. ; et al. | 2020-05-28 |
Monoclonal And Humanized Antibodies To A Cancer Glycopeptide
App 20200115466 - ZHOU; Dapeng ; et al. | 2020-04-16 |
Immunotherapeutic Tumor Treatment Method
App 20190275133 - Charych; Deborah H. ; et al. | 2019-09-12 |
Slc45a2 Peptides For Immunotherapy
App 20190169262 - LIZEE; Gregory ; et al. | 2019-06-06 |
Combination Of Topoisomerase-i Inhibitors With Immunotherapy In The Treatment Of Cancer
App 20180263971 - HWU; Patrick ; et al. | 2018-09-20 |
Biomarkers And Targets For Cancer Immunotherapy
App 20170363629 - RADVANYI; Laszlo ; et al. | 2017-12-21 |
B and T lymphocyte attenuator marker for use in adoptive T-cell therapy
Grant 9,512,401 - Radvanyi , et al. December 6, 2 | 2016-12-06 |
B And T Lymphocyte Attenuator Marker For Use In Adoptive T-cell Therapy
App 20130302300 - Radvanyi; Laszlo ; et al. | 2013-11-14 |
Tumor Targeted Delivery Of Immunomodulators By Nanopolymers
App 20120309691 - Zhou; Dapeng ; et al. | 2012-12-06 |
Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and therapeutic methods
Grant 8,252,545 - Hwu , et al. August 28, 2 | 2012-08-28 |
Chimeric receptor genes and cells transformed therewith
Grant 8,211,422 - Eshhar , et al. July 3, 2 | 2012-07-03 |
Chimeric Receptor Genes And Cells Transformed Therewith
App 20120093842 - Eshhar; Zelig ; et al. | 2012-04-19 |
Peptides Of A Melanoma Antigen And Their Use In Diagnostic, Prophylactic, And Therapeutic Methods
App 20100279950 - Hwu; Patrick ; et al. | 2010-11-04 |
Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and therapeutic methods
Grant 7,749,967 - Hwu , et al. July 6, 2 | 2010-07-06 |
Activated Dual Specificity Lymphocytes And Their Methods Of Use
App 20100158881 - Hwu; Patrick ; et al. | 2010-06-24 |
Method For Treating Cancer In Humans
App 20100135958 - Hwu; Patrick ; et al. | 2010-06-03 |
Activated dual specificity lymphocytes and their methods of use
Grant 7,723,111 - Hwu , et al. May 25, 2 | 2010-05-25 |
Methods and compositions for transforming dendritic cells and activating cells
App 20090263365 - Hwu; Patrick ; et al. | 2009-10-22 |
Peptides Of A Melanoma Antigen And Their Use In Diagnostic, Prophylactic, And Therapeutic Methods
App 20090010953 - Hwu; Patrick ; et al. | 2009-01-08 |
Peptides of melanoma antigen and their use in diagnostic, prophylactic and therapeutic methods
Grant 7,419,957 - Hwu , et al. September 2, 2 | 2008-09-02 |
Methods and compositions for transforming dendritic cells and activating T cells
Grant 7,378,277 - Hwu , et al. May 27, 2 | 2008-05-27 |
Method for treating cancer in humans
App 20050063947 - Hwu, Patrick ; et al. | 2005-03-24 |
Peptides of melanoma antigen and their use in diagnostic, prophylactic and therapeutic methods
App 20050065077 - Hwu, Patrick ; et al. | 2005-03-24 |
Methods and compositions for transforming dendritic cells and activating T cells
App 20040146492 - Hwu, Patrick ; et al. | 2004-07-29 |
Methods and compositions for transforming dendritic cells and activating T cells
Grant 6,734,014 - Hwu , et al. May 11, 2 | 2004-05-11 |
Activated dual specificity lymphocytes and their methods of use
App 20030026790 - Hwu, Patrick ; et al. | 2003-02-06 |
Chimeric Receptor Genes And Cells Transformed Therewith
App 20020137697 - ESHHAR, ZELIG A. ; et al. | 2002-09-26 |
| 